Johnson & Johnson (JNJ) Offers 2% Yield, Projects 8.2% Earnings Growth

Johnson & Johnson (JNJ) has a forward dividend yield of approximately 2% and has raised its quarterly cash payout for 65 years, averaging annual increases of 5.7% over the last decade. The company anticipates earnings growth of 8.2% in 2026 and 9.8% in 2027. Key drivers include a recently announced $5.5 billion settlement regarding talc product liabilities and a 73% sales growth in its Tremfya psoriasis treatment, generating $2 billion in revenue. This projected earnings growth supports potential for further dividend increases, making JNJ attractive for dividend-focused investors.